Recombinant SARS-CoV-2 Spike RBD-N Protein Chimera [His] (CAT#: VReP-101SX)

CAT Size Price Quantity  
For Research Use Only. We do not provide direct services or products for patients.

  • Product Overview
  • SARS-CoV-2 recombinant Protein, N-terminal Spike S1 RBD (319-541) fused to Nucleocapsid (237-419) protein with a linker HSA (human serum albumin), expressed in CHO cells, fused to 6xHis tag at C-terminal.
  • Source
  • CHO Cells
  • Tag
  • His
  • Target
  • SARS-CoV-2
  • Type
  • Viral Antigens
  • Applications
  • Used for detection and quantification of SARS-CoV-2 spike protein S1 (RBD) and Nucleocapsid (N) Protein from recombinant or biological samples.
  • Formulation
  • PBS, pH 7.4.
  • Purity
  • >95% pure by SDS-PAGE.
  • Product Form
  • Liquid
  • Storage
  • Store at -20°C.
  • Introduction
  • The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. The coronavirus genome encodes a spike protein, an envelope protein, a membrane protein, and a nucleoprotein. Among them, spike protein is the most important surface membrane protein of coronavirus.
  • Alternative Names
  • 2019 novel coronavirus; SARS-CoV-2; Coronaviridae
Related products

Online Inquiry For Research Use Only. We do not provide direct services or products for patients.

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.


Inquiry Basket